Download by
Scanning QR Code
No Stock Yet
Pharmaceutical and medical stocks continued to rebound. Yahong Pharmaceutical, Bailey Tianheng, Olin Biotech, First Pharmaceutical Holdings, Haichuang Pharmaceutical, and Cicheed rose more than 10%, while many stocks such as Cardiac Medicine, Jianfan Biol
A-share pharmaceutical and medical stocks fluctuated and rose. Dongxing Medical rose more than 7%, Heart Vein Medical and Chenxin Pharmaceutical rose more than 6%, and Sinopharm Hyundai, Jianmin Group, Kaili Healthcare, and Inke Healthcare followed suit.
East Star Medical: recently signed ventilator-related orders
Dongxing Medical: the company has not produced or represented antigen products at present.
Direct research | Dongxing Medical (301290.SZ): A new generation of electric endoscopic staplers achieved mass production, and there are currently no plans to set up factories overseas
The Zhitong Finance App learned that on December 12, Dongxing Medical (301290.SZ) said during an agency investigation that the company's next-generation electric endoscopic stapler products had obtained medical device registration certificates and production licenses, achieved mass production, and had begun promotion to the domestic market. Overseas sales revenue increased significantly compared to the previous year. Currently, the company is not planning to set up factories overseas. Regarding how to face the two-ticket system and collection, the company said that implementing the “two-ticket system” shortened the circulation process, made the company's factory price close to the sales price of the terminal hospital. Without considering other factors such as “volume procurement,” the company left the factory
The new shareholder of gem Star Medical is up more than 20%! Focus stapler, high book amount of goodwill
The latest total market capitalization is about 5.3 billion yuan
East Star Medical (301290.SZ): will be listed on Shenzhen Stock Exchange's growth Enterprise Market on November 30th.
On November 28th, 301290.SZ announced that its shares will be listed on the growth Enterprise Market of Shenzhen Stock Exchange on November 30th.
East Star Medical (301290.SZ) IPO subscription result: a total of 149500 shares were abandoned online and offline.
301290.SZ announced the results of its initial public offering and listing on the gem. The number of shares abandoned by online and offline investors is all underwritten by sponsor institutions (lead underwriters). The number of shares underwritten by sponsor institutions (lead underwriters) is 149466 shares, with an underwriting amount of 6.58996 million yuan. The proportion of the number of shares underwritten by the sponsor institution (lead underwriter) to the number of shares issued this time is 0.5968%. Among them, the number of shares abandoned by online investors was 149466 shares, and the amount of subscription abandoned by online investors was about 658.99.
East Star Medical (301290.SZ) disclosed the result of winning lottery: there were 22300 winning numbers.
On November 22nd, 301290.SZ announced the result of the initial public offering and the online lottery number of the gem listing. The details are as follows: where the investors participating in the online pricing issue hold the same Mantissa of the application matching number as the above-mentioned number, it will be the winning number. There are 22336 winning numbers, and each winning number can only subscribe for 22336 A shares of Jiangsu Dongxing Wisdom Medical Technology Co., Ltd.
The success rate of online issuance of East Star Medical (301290.SZ) after callback is 0.0215%.
Zhitong Financial App News, East Star Medical (301290.SZ) issued an announcement that after the callback mechanism was launched, the final number of shares issued offline was 12.7413 million shares, accounting for 53.29% of the total number of shares issued after deducting the final strategic placement, while the final number of shares issued online was 11.168 million shares, accounting for 46.71% of the total number of shares issued after deducting the final strategic placement. After callback, the success rate of this online offering is 0.0214502942%, and the effective purchase multiple is 4661.94 times.
Loading...
No Stock Yet